首页> 美国卫生研究院文献>Patient preference and adherence >Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

【2h】

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

机译：与长期控制酪氨酸激酶抑制剂治疗慢性粒细胞白血病相关的药物相关问题：一项定性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposePoor adherence to tyrosine kinase inhibitors (TKIs) could compromise the control of chronic myeloid leukemia (CML) and contributes to poorer survival. Little is known about how medication-related issues affect CML patients’ adherence to TKI therapy in Malaysia. This qualitative study aimed to explore these issues.

机译：目的对酪氨酸激酶抑制剂（TKIs）的依从性差可能会损害对慢性粒细胞白血病（CML）的控制，并导致较差的生存。关于药物相关问题如何影响CML患者在马来西亚坚持TKI治疗的知之甚少。这项定性研究旨在探讨这些问题。

著录项

期刊名称 Patient preference and adherence
作者
Bee Kim Tan; Seng Beng Tan; Li-Chia Chen; Kian Meng Chang; Siew Siang Chua; Sharmini Balashanker; Habiba Nazeera Begum Kamarul Jaman; Syed Carlo Edmund; Ping Chong Bee;
展开▼
作者单位

展开▼
年(卷),期 2017(11),-1
年度 2017
页码 1027–1034
总页数 8
原文格式 PDF
正文语种
中图分类基础医学;
关键词
medication-related issues adherence tyrosine kinase inhibitors chronic myeloid leukemia qualitative study thematic analysis;

机译：药物相关问题;依从性;酪氨酸激酶抑制剂;慢性粒细胞白血病;定性研究;主题分析;

相似文献

外文文献
中文文献
专利

1. Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study [J] . Bee Kim Tan, Seng Beng Tan, Li-Chia Chen, Patient Preference and Adherence . 2017,第1期

机译：与长期控制酪氨酸激酶抑制剂治疗慢性粒细胞白血病相关的药物相关问题：一项定性研究
2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lympoblastic Leukemia wit [J] . B. J. Druker, M. Talpaz, D. J. Resta, Chemtracts . 2001,第13期

机译：BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病中的功效和安全性BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病和急性淋巴细胞白血病机智的爆发危机中的活性
3. Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental PreePost Intervention Multicenter Pilot Study [J] . Leader Avi, Benyamini Noam, Gafter-Gvili Anat, Clinical lymphoma, myeloma & leukemia . 2018,第11期

机译：依赖增强干预措施对慢性髓性白血病酪氨酸激酶抑制剂治疗拮抗性的效果（Take-IT）：一种准实验性Preepost干预多中心试验研究
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
6. Chronic myeloid leukemia patients’ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians [O] . Meri Kekäle, Kimmo Talvensaari, Perttu Koskenvesa, 2014

机译：慢性粒细胞白血病患者对口服酪氨酸激酶抑制剂的依从性与他们的医生对依从性的比较
7. Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study [O] . Tan, Bee Kim, Tan, Seng Beng, Chen, Li-Chia, 2017

机译：与坚持长期酪氨酸激酶抑制剂控制慢性粒细胞白血病相关的药物相关问题：定性研究

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

摘要

著录项

相似文献

相关主题

期刊订阅